Resources with keywords: vaccines
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021 (NEW 11/2, Website, Publication)
CDC/MMWR
22 October 2021
Olson SM, Newhams MM, Halasa NB, et al.
Sabin Vaccine Institute Receives Additional $34.5 Million from BARDA for Further Development of Ebola Sudan and Marburg Vaccines
The Sabin Vaccine Institute
21 October 2021
Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021 (NEW 10/15, Website, Publication)
CDC/MMWR
1 October 2021
Hause AM, Baggs J, Gee J, et al.
Multicomponent Strategies to Prevent SARS-CoV-2 Transmission — Nine Overnight Youth Summer Camps, United States, June–August 2021 (NEW 10/15, Website, Publication)
CDC/MMWR
8 October 2021
Van Naarden Braun K, Drexler M, Rozenfeld RA, et al.
Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age (NEW 10/15, Website, News)
Pfizer
28 September 2021
Johnson & Johnson’s two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response
Outbreak News Today
7 October 2021
Malenfant JH, Joyce A, Choi MJ, et al.
The ACIP has expanded the recommendation for Ebola vaccine to health care personnel at special pathogens treatment centers and laboratorians and support staff members at Laboratory Response Network facilities.
Booster Shots and Third Doses for COVID-19 Vaccines: What You Need to Know (NEW 10/6, Website)
Johns Hopkins University Medicine
15 August 2021
